Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection

World Journal of Gastroenterology

Volumn 12, Issue 13, 2006, Pages 2089-2094

  Sekiguchi, Tetsuro ^a   Nagamine, Takeaki ^a   Takagi, Hitoshi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus; Liver cirrhosis; Natural killer cell; Splenectomy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; BILIRUBIN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; VIRUS RNA;

ADULT; AGED; ARTICLE; CD4 CD8 RATIO; CELL ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; SEROTYPE; SPLENECTOMY; THROMBOCYTE;

EID: 33646447578     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i13.2089     Document Type: Article

References (41)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-S46
2. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N, Kumada H. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998; 28: 930-938
3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675
4. Okuda K, Yokosuka O. Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4-23 years of follow-up. World J Gastroenterol 2004; 10: 2209-2212
5. Hattori Y, Orito E, Ohno T, Sugauchi F, Suzuki S, Sugiura M, Suzumori K, Hattori K, Ueda R, Mizokami M. Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection. J Med Virol 2003; 71: 205-211
6. Watanabe H, Saito T, Shinzawa H, Okumoto K, Hattori E, Adachi T, Takeda T, Sugahara K, Ito JI, Saito K, Togashi H, Suzuki R, Hayashi M, Miyamura T, Matsuura Y, Kawata S. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 2003; 71: 56-61
7. Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, Mele A, Giampaoli S, Rapicetta M. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50: 693-696
8. Fukuizumi K, Sata M, Suzuki H, Kumashiro R, Tanikawa K. Natural disappearance of serum HCV RNA: prospective study in a hyperendemic area. Hepatol Res 1997; 9: 144-151
9. Rosen HR. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury. Liver Transpl 2003; 9: S35-S43
10. Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM. T-cell - mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995; 22: 1368-1373
11. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005; 436: 946-952
12. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999; 163: 2314-2321
13. Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ. Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 2004; 76: 1171-1179
14. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002; 195: 43-49
15. Ortaldo JR, Bere EW, Hodge D, Young HA. Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J Immunol 2001; 166: 4994-4999
16. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001; 13: 458-464
17. Lin AW, Gonzalez SA, Cunningham-Rundles S, Dorante G, Marshall S, Tignor A, Ha C, Jacobson IM, Talal AH. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection. Clin Exp Immunol 2004; 137: 408-416
18. Van Thiel DH, Zhang X, Baddour N, Wright HI, Friedlander L, Gavaler JS. Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha. Dig Dis Sci 1994; 39: 970-976
19. Laso FJ, Madruga JI, Giron JA, Lopez A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997; 25: 1096-1100
20. Ledesma F, Echevarria S, Casafont F, Lozano JL, Pons-Romero F. Natural killer cell activity in alcoholic cirrhosis: influence of nutrition. Eur J Clin Nutr 1990; 44: 733-740
21. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 1998; 83: 58-63
22. Chuang WL, Liu HW, Chang WY. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer 1990; 65: 926-930
23. Kakumu S, Hirofuji H, Fuji A, Tahara H, Yoshioka K. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma. J Clin Lab Immunol 1988; 26: 29-32
24. Takegoshi K, Ogai H, Sugimoto T, Ohmoto Y. Production of IFN-gamma and IL-12 by peripheral whole blood is maintained in hepatitis C virus patients with persistently normal alanine transferase activity; A preliminary report. Hepatol Res 2004; 29: 81-88
25. Kawarabayashi N, Seki S, Hatsuse K, Ohkawa T, Koike Y, Aihara T, Habu Y, Nakagawa R, Ami K, Hiraide H, Mochizuki H. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000; 32: 962-969
26. Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg 1973; 66: 677-685
27. Weese JL, Starling JR, Yale CE. Control of bleeding esophageal varices by transabdominal esophageal transection, gastric devascularization, and splenectomy. Surg Gastroenterol 1984; 3: 31-36
28. Samimi F, Irish WD, Eghtesad B, Demetris AJ, Starzl TE, Fung JJ. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci 1998; 43: 1931-1937
29. Linet MS, Nyren O, Gridley G, Adami HO, Buckland JD, McLaughlin JK, Fraumeni JF Jr. Causes of death among patients surviving at least one year following splenectomy. Am J Surg 1996; 172: 320-323
30. Joag SV, Stephens EB, Adams RJ, Foresman L, Narayan O. Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 1994; 200: 436-446
31. Pereira LM, Melo MC, Saleh MG, Massarolo P, Koskinas J, Domingues AL, Spinelli V, Mies S, Williams R, McFarlane IG. Hepatitis C virus infection in Schistosomiasis mansoni in Brazil. J Med Virol 1995; 45: 423-428
32. Ferrante A, Kiroff GK, Drew PA. Elevated natural killer (NK) cytotoxicity of mononuclear leucocytes from splenectomized patients: increase in Leu-7+ and Leu-11+ leucocytes. Clin Exp Immunol 1986; 64: 173-180
33. Abe T, Masuda T, Satodate R. Phagocytic activity of Kupffer cells in splenectomized rats. Virchows Arch A Pathol Anat Histopathol 1988; 413: 457-462
34. Tsukiyama-Kohara K, Kohara M, Yamaguchi K, Maki N, Toyoshima A, Miki K, Tanaka S, Hattori N, Nomoto A. A second group of hepatitis C viruses. Virus Genes 1991; 5: 243-254
35. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74 (Pt 4): 661-668
36. Young KK, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J Clin Microbiol 1995; 33: 654-657
37. Nolte FS, Thurmond C, Fried MW. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J Clin Microbiol 1995; 33: 1775-1778
38. Oshimi K, Oshimi Y, Satake M, Mizoguchi H. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes. J Exp Med 1985; 162: 472-486
39. Ikuta S, Ono S, Kinoshita M, Seki S, Hiraide H, Mochizuki H. Enhanced interferon-gamma production and bacterial clearance in the liver of splenectomized mice in the models of Escherichia coli injection or intestinal obstruction. Shock 2004; 21: 452-457
40. Podevin P, Calmus Y, Bonnefis MT, Veyrunes C, Chereau C, Poupon R. Effect of cholestasis and bile acids on interferon-induced 2′,5′-adenylate synthetase and NK cell activities. Gastroenterology 1995; 108: 1192-1198
41. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20